FDA Inspection 1220006 — Department of Defense - Army (Landstuhl Regional Medical Center)
The FDA completed an inspection of Department of Defense - Army (Landstuhl Regional Medical Center) on August 25, 2023 in Landstuhl. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Landstuhl (Germany)